Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven M. Paul files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Third Rock Ventures V, L.P. - $34.39M in RAPP purchases and sales in the last 12 months
- ARCH Venture Partners XII, LLC - $19.80M in SPTX purchases and sales in the last 12 months
- Abraham Ceesay - $5.93M in RAPP purchases and sales in the last 12 months
- Krishnaswamy Yeleswaram - $4.46M in RAPP purchases and sales in the last 12 months
- Cheryl Gault - $1.24M in RAPP purchases and sales in the last 12 months
- David Bredt - $1.14M in RAPP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven M. Paul?
Steven M. Paul is a corporate insider of Rapport Therapeutics, Inc. (RAPP). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Steven M. Paul last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 4 filings going back to 2025.
Has Steven M. Paul been buying or selling stock?
Recorded transactions: 2 open-market purchases ($1.03M) and 0 open-market sales across all tracked filings.
